Black Hawk Acquisition Corporation Rights (BKHAR) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Black Hawk Acquisition Corporation Rights, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$1.57
+4.67% today
Market cap
—
Overall quality
42/100
Kronos AI 30-day
—
Black Hawk Acquisition Corporation Rights (BKHAR) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances). It trades at $1.57, up 4.67% today, at 2.2 times earnings. Its overall quality score is 42 out of 100, ranked against the whole US market.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 50 |
| Solvency | 32 |
| Growth | 44 |
| Overall | 42 |
| P/E | 2.2 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.